Impact of diffusion-weighted imaging alberta stroke program early computed tomography score on the success of endovascular reperfusion therapy

Stroke

Volumn 45, Issue 7, 2014, Pages 1992-1998

  Inoue, Manabu ^a   Olivot, Jean Marc ^a,b   Labreuche, Julien ^d,e   Mlynash, Michael ^a   Tai, Waimea ^f   Albucher, Jean François ^b   Meseguer, Elena ^c,d   Amarenco, Pierre ^c,d   Mazighi, Mikael ^c,d  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b CHU PURPAN   (France)

^c BICHAT HOSPITAL   (France)

^d Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^e UNIV LILLE   (France)

^f NONE

Author keywords

brain magnetic resonance imaging; diffusion; endovascular therapy; stroke

Indexed keywords

ALTEPLASE; GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN ISCHEMIA; DIASTOLIC BLOOD PRESSURE; DIFFUSION WEIGHTED IMAGING; DIFFUSION WEIGHTED IMAGING ALBERTA STROKE PROGRAM EARLY COMPUTED TOMOGRAPHY SCORE; ENDOVASCULAR SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

BRAIN MAGNETIC RESONANCE IMAGING; DIFFUSION; ENDOVASCULAR THERAPY; STROKE;

AGED; AGED, 80 AND OVER; CEREBRAL INFARCTION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84903767196     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005084     Document Type: Article

References (25)

1. Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, et al. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab. 2010;30: 1214-1225.
2. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M, et al. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke. 2011;42: 1270-1275.
3. Olivot JM, Mosimann PJ, Labreuche J, Inoue M, Meseguer E, Desilles JP, et al. Impact of diffusion-weighted imaging lesion volume on the success of endovascular reperfusion therapy. Stroke. 2013;44: 2205-2211.
4. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355: 1670-1674. (Pubitemid 30248478)
5. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, et al PROACT-II Investigators. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003;34: 1925-1931. (Pubitemid 36944782)
6. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: A prospective comparison. Lancet. 2007;369: 293-298. (Pubitemid 46136489)
7. Baird AE, Dambrosia J, Janket S, Eichbaum Q, Chaves C, Silver B, et al. A three-item scale for the early prediction of stroke recovery. Lancet. 2001;357: 2095-2099. (Pubitemid 32607454)
8. Oppenheim C, Samson Y, Manaï R, Lalam T, Vandamme X, Crozier S, et al. Prediction of malignant middle cerebral artery infarction by diffusionweighted imaging. Stroke. 2000;31: 2175-2181.
9. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, González RG. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke. 2009;40: 2046-2054.
10. de Margerie-Mellon C, Turc G, Tisserand M, Naggara O, Calvet D, Legrand L, et al. Can DWI-ASPECTS substitute for lesion volume in acute stroke? Stroke. 2013;44: 3565-3567.
11. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, et al ASPECTS Study Group. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusionweighted imaging. J Neurol Neurosurg Psychiatry. 2005;76: 1528-1533. (Pubitemid 41531700)
12. Turc G, Apoil M, Naggara O, Calvet D, Lamy C, Tataru AM, et al. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke. Stroke. 2013;44: 1323-1328.
13. Singer OC, Kurre W, Humpich MC, Lorenz MW, Kastrup A, Liebeskind DS, et al; MR Stroke Study Group Investigators. Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWIASPECTS. Stroke. 2009;40: 2743-2748.
14. Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, et al. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent riskfactor assessment and improvement (SAMURAI) rt-PA registry. Stroke. 2011;42: 2196-2200.
15. Mazighi M, Chaudhry SA, Ribo M, Khatri P, Skoloudik D, Mokin M, et al. Impact of onset-to-reperfusion time on stroke mortality: A collaborative pooled analysis. Circulation. 2013;127: 1980-1985.
16. Aoki J, Kimura K, Shibazaki K, Sakamoto Y. DWI-ASPECTS as a predictor of dramatic recovery after intravenous recombinant tissue plasminogen activator administration in patients with middle cerebral artery occlusion. Stroke. 2013;44: 534-537.
17. Meseguer E, Mazighi M, Lapergue B, Labreuche J, Sirimarco G, Gonzalez-Valcarcel J, et al. Outcomes after thrombolysis in AIS according to prior statin use: A registry and review. Neurology. 2012;79: 1817-1823.
18. Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallée PC, et al RECANALISE Investigators. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): A prospective cohort study. Lancet Neurol. 2009;8: 802-809.
19. Rouchaud A, Mazighi M, Labreuche J, Meseguer E, Serfaty JM, Laissy JP, et al. Outcomes of mechanical endovascular therapy for acute ischemic stroke: A clinical registry study and systematic review. Stroke. 2011;42: 1289-1294.
20. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312: 932-936.
21. Straka M, Albers GW, Bammer R. Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging. 2010;32: 1024-1037.
22. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352: 1245-1251. (Pubitemid 28470336)
23. Lin K, Lee SA, Zink WE. What ASPECTS value best predicts the 100- mL threshold on diffusion weighted imaging? Study of 150 patients with middle cerebral artery stroke. J Neuroimaging. 2011;21: 229-231.
24. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al; DEFUSE 2 study investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): A prospective cohort study. Lancet Neurol. 2012;11: 860-867.
25. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, et al EPITHET-DEFUSE Investigators. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab. 2012;32: 50-56.